Rational Design of a Detargeted Vesiculovirus Fusogen to Enable Targeted In Vivo Gene Delivery

Download PDF
Read Article

Interius

Interius is now part of Kite, a Gilead Company. 

We are singularly focused on achieving cures with cell therapy.
Learn More About Kite